About KLIMED Marek Klimkiewicz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at KLIMED Marek Klimkiewicz
During the past decade, KLIMED Marek Klimkiewicz conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Completed
500
Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
1996-07-01
Unknown status
4,000
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
1997-11-01
Completed
859
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
1999-09-01
2005-12-01
Completed
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
2000-06-01
2002-04-01
Completed
730
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz" #1 sponsor was "Pfizer" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Bayer" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KLIMED Marek Klimkiewicz"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at KLIMED Marek Klimkiewicz
According to Clinical.Site data, the most researched conditions in "KLIMED Marek Klimkiewicz" are
"Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials), "COVID-19" (2 trials), "Alzheimer Disease" (1 trials) and "Alzheimers Disease" (1 trials). Many other conditions were trialed in "KLIMED Marek Klimkiewicz" in a lesser frequency.
Clinical Trials Intervention Types at KLIMED Marek Klimkiewicz
Most popular intervention types in "KLIMED Marek Klimkiewicz" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Empagliflozin" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "0 mg Induction ONLY" (1 trials). Other intervention names were less common.
Clinical Trials Genders at KLIMED Marek Klimkiewicz
The vast majority of trials in "KLIMED Marek Klimkiewicz" are
15 trials for "All" genders.
Clinical Trials Status at KLIMED Marek Klimkiewicz
Currently, there are NaN active trials in "KLIMED Marek Klimkiewicz".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in KLIMED Marek Klimkiewicz,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in KLIMED Marek Klimkiewicz, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".